{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T22:38:34Z","timestamp":1779921514120,"version":"3.53.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,9]]},"DOI":"10.7759\/cureus.51943","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T15:52:04Z","timestamp":1704815524000},"source":"Crossref","is-referenced-by-count":3,"title":["Antipyretic Use in Noncritically Ill Patients With Fever: A Review"],"prefix":"10.7759","author":[{"given":"Khawar Tariq","family":"Mehmood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahad","family":"Al-Baldawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Z\u00fa\u00f1iga Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Z\u00fa\u00f1iga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1100\/tsw.2010.50","article-title":"Fever","volume":"10","author":"Bartfai T","year":"2010","unstructured":"Bartfai T, Conti B. Fever. ScientificWorldJournal. 2010, 10:490-503. 10.1100\/tsw.2010.50","journal-title":"ScientificWorldJournal"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0891-5520(05)70282-8","article-title":"The adaptive value of fever","volume":"10","author":"Kluger MJ","year":"1996","unstructured":"Kluger MJ, Kozak W, Conn CA, Leon LR, Soszynski D. The adaptive value of fever. Infect Dis Clin North Am. 1996, 10:1-20. 10.1016\/s0891-5520(05)70282-8","journal-title":"Infect Dis Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.151.1.7812538","article-title":"Effect of cooling on oxygen consumption in febrile critically ill patients","volume":"151","author":"Manthous CA","year":"1995","unstructured":"Manthous CA, Hall JB, Olson D, et al.. Effect of cooling on oxygen consumption in febrile critically ill patients. Am J Respir Crit Care Med. 1995, 151:10-4. 10.1164\/ajrccm.151.1.7812538","journal-title":"Am J Respir Crit Care Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012689","article-title":"Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest","volume":"346","year":"2002","unstructured":"Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002, 346.549-56. 10.1056\/NEJMoa012689","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa003289","article-title":"Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia","volume":"346","author":"Bernard SA","year":"2002","unstructured":"Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002, 346:557-63. 10.1056\/NEJMoa003289","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1086\/317516","article-title":"External cooling in the management of fever","volume":"31 Suppl 5","author":"Axelrod P","year":"2000","unstructured":"Axelrod P. External cooling in the management of fever. Clin Infect Dis. 2000, 31 Suppl 5:S224-9. 10.1086\/317516","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2174\/138945009789108828","article-title":"Which drugs for the control of fever in critical patients","volume":"10","author":"Fumagalli R","year":"2009","unstructured":"Fumagalli R, Bellani G, Perri A. Which drugs for the control of fever in critical patients. Curr Drug Targets. 2009, 10:881-6. 10.2174\/138945009789108828","journal-title":"Curr Drug Targets"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S1441-2772(23)01852-5","article-title":"Fever and fever management among intensive care patients with known or suspected infection: a multicentre prospective cohort study","volume":"13","author":"Young P","year":"2011","unstructured":"Young P, Saxena M, Eastwood GM, Bellomo R, Beasley R. Fever and fever management among intensive care patients with known or suspected infection: a multicentre prospective cohort study. Crit Care Resusc. 2011, 13:97-102. 10.1016\/S1441-2772(23)01852-5","journal-title":"Crit Care Resusc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2011.11.016","article-title":"Fever in non-neurological critically ill patients: a systematic review of observational studies","volume":"27","author":"Egi M","year":"2012","unstructured":"Egi M, Morita K. Fever in non-neurological critically ill patients: a systematic review of observational studies. J Crit Care. 2012, 27:428-33. 10.1016\/j.jcrc.2011.11.016","journal-title":"J Crit Care"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4037\/15597768-2007-1008","article-title":"Fever: applying research to bedside practice","volume":"18","author":"Henker R","year":"2007","unstructured":"Henker R, Carlson KK. Fever: applying research to bedside practice. AACN Adv Crit Care. 2007, 18:76-87. 10.4037\/15597768-2007-1008","journal-title":"AACN Adv Crit Care"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1258\/jrsm.2010.090441","article-title":"The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analysis","volume":"103","author":"Eyers S","year":"2010","unstructured":"Eyers S, Weatherall M, Shirtcliffe P, Perrin K, Beasley R. The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analysis. J R Soc Med. 2010, 103:403-11. 10.1258\/jrsm.2010.090441","journal-title":"J R Soc Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)02255-1","article-title":"Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria","volume":"350","author":"Brandts CH","year":"1997","unstructured":"Brandts CH, Ndjav\u00e9 M, Graninger W, Kremsner PG. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet. 1997, 350:704-9. 10.1016\/S0140-6736(97)02255-1","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181aa5241","article-title":"Mechanisms of action, physiological effects, and complications of hypothermia","volume":"37","author":"Polderman KH","year":"2009","unstructured":"Polderman KH. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med. 2009, 37:S186-202. 10.1097\/CCM.0b013e3181aa5241","journal-title":"Crit Care Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2346.2000.00607.x","article-title":"The effect of a single intravenous dose of metamizol 2 g, ketorolac 30 mg and propacetamol 1 g on haemodynamic parameters and postoperative pain after heart surgery","volume":"17","author":"Avellaneda C","year":"2000","unstructured":"Avellaneda C, G\u00f3mez A, Martos F, Rubio M, Sarmiento J, de la Cuesta FS. The effect of a single intravenous dose of metamizol 2 g, ketorolac 30 mg and propacetamol 1 g on haemodynamic parameters and postoperative pain after heart surgery. Eur J Anaesthesiol. 2000, 17:85-90. 10.1046\/j.1365-2346.2000.00607.x","journal-title":"Eur J Anaesthesiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s1036-7314(97)70414-4","article-title":"Paracetamol administration is associated with hypotension in the critically ill","volume":"10","author":"Boyle M","year":"1997","unstructured":"Boyle M, Hundy S, Torda TA. Paracetamol administration is associated with hypotension in the critically ill. Aust Crit Care. 1997, 10:120-2. 10.1016\/s1036-7314(97)70414-4","journal-title":"Aust Crit Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5468","article-title":"Individual differences in normal body temperature: longitudinal big data analysis of patient records","volume":"359","author":"Obermeyer Z","year":"2017","unstructured":"Obermeyer Z, Samra JK, Mullainathan S. Individual differences in normal body temperature: longitudinal big data analysis of patient records. BMJ. 2017, 359:j5468. 10.1136\/bmj.j5468","journal-title":"BMJ"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1086\/317513","article-title":"Circulating cytokines as mediators of fever","volume":"31 Suppl 5","author":"Netea MG","year":"2000","unstructured":"Netea MG, Kullberg BJ, Van der Meer JW. Circulating cytokines as mediators of fever. Clin Infect Dis. 2000, 31 Suppl 5:S178-84. 10.1086\/317513","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406303302609","article-title":"The neurologic basis of fever","volume":"330","author":"Saper CB","year":"1994","unstructured":"Saper CB, Breder CD. The neurologic basis of fever. N Engl J Med. 1994, 330:1880-6. 10.1056\/NEJM199406303302609","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/nri3843","article-title":"Fever and the thermal regulation of immunity: the immune system feels the heat","volume":"15","author":"Evans SS","year":"2015","unstructured":"Evans SS, Repasky EA, Fisher DT. Fever and the thermal regulation of immunity: the immune system feels the heat. Nat Rev Immunol. 2015, 15:335-49. 10.1038\/nri3843","journal-title":"Nat Rev Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/00001432-200206000-00005","article-title":"Fever: beneficial and detrimental effects of antipyretics","volume":"15","author":"Greisman LA","year":"2002","unstructured":"Greisman LA, Mackowiak PA. Fever: beneficial and detrimental effects of antipyretics. Curr Opin Infect Dis. 2002, 15:241-5. 10.1097\/00001432-200206000-00005","journal-title":"Curr Opin Infect Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.4.449","article-title":"Antipyretic therapy: physiologic rationale, diagnostic implications, and clinical consequences","volume":"160","author":"Plaisance KI","year":"2000","unstructured":"Plaisance KI, Mackowiak PA. Antipyretic therapy: physiologic rationale, diagnostic implications, and clinical consequences. Arch Intern Med. 2000, 160:449-56. 10.1001\/archinte.160.4.449","journal-title":"Arch Intern Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2008.12.003","article-title":"Sepsis and septic shock: a history","volume":"25","author":"Funk DJ","year":"2009","unstructured":"Funk DJ, Parrillo JE, Kumar A. Sepsis and septic shock: a history. Crit Care Clin. 2009, 25:83-101, viii. 10.1016\/j.ccc.2008.12.003","journal-title":"Crit Care Clin"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1990.00040031589005","article-title":"Antipyresis and fever","volume":"150","author":"Styrt B","year":"1990","unstructured":"Styrt B, Sugarman B. Antipyresis and fever. Arch Intern Med. 1990, 150:1589-97. 10.1001\/archinte.1990.00040031589005","journal-title":"Arch Intern Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(01)00834-8","article-title":"Antipyretics: mechanisms of action and clinical use in fever suppression","volume":"111","author":"Aronoff D","year":"2001","unstructured":"Aronoff D, Neilson E. Antipyretics: mechanisms of action and clinical use in fever suppression. Am J Med. 2001, 111:304-15. 10.1016\/s0002-9343(01)00834-8","journal-title":"Am J Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050215","article-title":"Evaluation of ibuprofen versus aspirin and paracetamol on efficacy and comfort in children with fever","volume":"51","author":"Autret E","year":"1997","unstructured":"Autret E, Reboul-Marty J, Henry-Launois B, et al.. Evaluation of ibuprofen versus aspirin and paracetamol on efficacy and comfort in children with fever. Eur J Clin Pharmacol. 1997, 51:367-71. 10.1007\/s002280050215","journal-title":"Eur J Clin Pharmacol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.100","article-title":"Ibuprofen, acetaminophen, and placebo treatment of febrile children","volume":"46","author":"Walson PD","year":"1989","unstructured":"Walson PD, Galletta G, Braden NJ, Alexander L. Ibuprofen, acetaminophen, and placebo treatment of febrile children. Clin Pharmacol Ther. 1989, 46:9-17. 10.1038\/clpt.1989.100","journal-title":"Clin Pharmacol Ther"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1995.02170190042007","article-title":"Antipyretic efficacy of ibuprofen and acetaminophen in children with febrile seizures","volume":"149","author":"Van Esch A","year":"1995","unstructured":"Van Esch A, Van Steensel-Moll HA, Steyerberg EW, Offringa M, Habbema JD, Derksen-Lubsen G. Antipyretic efficacy of ibuprofen and acetaminophen in children with febrile seizures. Arch Pediatr Adolesc Med. 1995, 149:632-7. 10.1001\/archpedi.1995.02170190042007","journal-title":"Arch Pediatr Adolesc Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199300461-00061","article-title":"Tolerability of nimesulide and ketoprofen in paediatric patients with traumatic or surgical fractures","volume":"46 Suppl 1","author":"Facchini R","year":"1993","unstructured":"Facchini R, Selva G, Peretti G. Tolerability of nimesulide and ketoprofen in paediatric patients with traumatic or surgical fractures. Drugs. 1993, 46 Suppl 1:238-41. 10.2165\/00003495-199300461-00061","journal-title":"Drugs"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198806093182301","article-title":"Detection of circulating tumor necrosis factor after endotoxin administration","volume":"318","author":"Michie HR","year":"1988","unstructured":"Michie HR, Manogue KR, Spriggs DR, et al.. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med. 1988, 318:1481-6. 10.1056\/NEJM198806093182301","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199703273361303","article-title":"The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group","volume":"336","author":"Bernard GR","year":"1997","unstructured":"Bernard GR, Wheeler AP, Russell JA, et al.. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med. 1997, 336:912-8. 10.1056\/NEJM199703273361303","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1994.tb02050.x","article-title":"Evaluation of the antipyretic effect of ketorolac, acetaminophen, and placebo in endotoxin-induced fever","volume":"34","author":"Vargas R","year":"1994","unstructured":"Vargas R, Maneatis T, Bynum L, Peterson C, McMahon FG. Evaluation of the antipyretic effect of ketorolac, acetaminophen, and placebo in endotoxin-induced fever. J Clin Pharmacol. 1994, 34:848-53. 10.1002\/j.1552-4604.1994.tb02050.x","journal-title":"J Clin Pharmacol"},{"key":"ref32","article-title":"Antipyretic activity of nimesulide suppositories: double blind versus diclofenac and placebo","volume":"23","author":"Reiner M","year":"1985","unstructured":"Reiner M, Cereghetti S, Haeusermann M, Monti T. Antipyretic activity of nimesulide suppositories: double blind versus diclofenac and placebo. Int J Clin Pharmacol Ther Toxicol. 1985, 23:673-7.","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1987.03390140075030","article-title":"Public Health Service study of Reye's syndrome and medications. Report of the main study","volume":"257","author":"Hurwitz ES","year":"1987","unstructured":"Hurwitz ES, Barrett MJ, Bregman D, et al.. Public Health Service study of Reye's syndrome and medications. Report of the main study. JAMA. 1987, 257:1905-11. 10.1001\/jama.1987.03390140075030","journal-title":"JAMA"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1177\/106002808602000209","article-title":"Aspirin and Reye's syndrome: the change in prescribing habits of health professionals","volume":"20","author":"Rahwan GL","year":"1986","unstructured":"Rahwan GL, Rahwan RG. Aspirin and Reye's syndrome: the change in prescribing habits of health professionals. Drug Intell Clin Pharm. 1986, 20:143-5. 10.1177\/106002808602000209","journal-title":"Drug Intell Clin Pharm"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(97)00204-0","article-title":"Use and benefits of nonsteroidal anti-inflammatory drugs","volume":"104","author":"Brooks P","year":"1998","unstructured":"Brooks P. Use and benefits of nonsteroidal anti-inflammatory drugs. Am J Med. 1998, 104:9-13. 10.1016\/s0002-9343(97)00204-0","journal-title":"Am J Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane JR","year":"1998","unstructured":"Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998, 38:97-120. 10.1146\/annurev.pharmtox.38.1.97","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-10-787","article-title":"Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis","volume":"115","author":"Gabriel SE","year":"1991","unstructured":"Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med. 1991, 115:787-96. 10.7326\/0003-4819-115-10-787","journal-title":"Ann Intern Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2014.907792","article-title":"Cardiovascular events associated with the long-term use of NSAIDs: a review of randomized controlled trials and observational studies","volume":"13","author":"Salvo F","year":"2014","unstructured":"Salvo F, Antoniazzi S, Duong M, et al.. Cardiovascular events associated with the long-term use of NSAIDs: a review of randomized controlled trials and observational studies. Expert Opin Drug Saf. 2014, 13:573-85. 10.1517\/14740338.2014.907792","journal-title":"Expert Opin Drug Saf"},{"key":"ref39","article-title":"NSAIDs and kidney","volume":"52","author":"Ejaz P","year":"2004","unstructured":"Ejaz P, Bhojani K, Joshi VR. NSAIDs and kidney. J Assoc Physicians India. 2004, 52:632-40.","journal-title":"J Assoc Physicians India"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114147","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective","volume":"180","author":"Bindu S","year":"2020","unstructured":"Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol. 2020, 180:114147. 10.1016\/j.bcp.2020.114147","journal-title":"Biochem Pharmacol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199710163371602","article-title":"Acetaminophen toxicity in an urban county hospital","volume":"337","author":"Schi\u00f8dt FV","year":"1997","unstructured":"Schi\u00f8dt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban county hospital. N Engl J Med. 1997, 337:1112-7. 10.1056\/NEJM199710163371602","journal-title":"N Engl J Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03520230055038","article-title":"Association of acetaminophen hepatotoxicity with fasting and ethanol use","volume":"272","author":"Whitcomb D","year":"1994","unstructured":"Whitcomb D, Block G. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA. 1994, 272:1845-50. 10.1001\/jama.1994.03520230055038","journal-title":"JAMA"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1086\/317510","article-title":"Brief history of antipyretic therapy","volume":"31 Suppl 5","author":"Mackowiak PA","year":"2000","unstructured":"Mackowiak PA. Brief history of antipyretic therapy. Clin Infect Dis. 2000, 31 Suppl 5:S154-6. 10.1086\/317510","journal-title":"Clin Infect Dis"},{"key":"ref44","article-title":"Antipyretic therapy in the febrile child","volume":"11","author":"Drwal-Klein L","year":"1992","unstructured":"Drwal-Klein L, Phelps S. Antipyretic therapy in the febrile child. Clin Pharm. 1992, 11:1005-21.","journal-title":"Clin Pharm"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-198708000-00005","article-title":"Acetaminophen prophylaxis of adverse reactions following vaccination of infants with diphtheria-pertussis-tetanus toxoids-polio vaccine","volume":"6","author":"Ipp MM","year":"1987","unstructured":"Ipp MM, Gold R, Greenberg S, et al.. Acetaminophen prophylaxis of adverse reactions following vaccination of infants with diphtheria-pertussis-tetanus toxoids-polio vaccine. Pediatr Infect Dis J. 1987, 6:721-5. 10.1097\/00006454-198708000-00005","journal-title":"Pediatr Infect Dis J"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1075449","article-title":"Discomfort relief after paracetamol administration in febrile children admitted to a third level paediatric emergency department","volume":"11","author":"Chiappini E","year":"2023","unstructured":"Chiappini E, Bestetti M, Masi S, Paba T, Venturini E, Galli L. Discomfort relief after paracetamol administration in febrile children admitted to a third level paediatric emergency department. Front Pediatr. 2023, 11:1075449. 10.3389\/fped.2023.1075449","journal-title":"Front Pediatr"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/s0885-3924(02)00520-1","article-title":"Symptomatic intravenous antipyretic therapy: efficacy of metamizol, diclofenac, and propacetamol","volume":"24","author":"Oborilov\u00e1 A","year":"2002","unstructured":"Oborilov\u00e1 A, Mayer J, Posp\u00edsil Z, Kor\u00edstek Z. Symptomatic intravenous antipyretic therapy: efficacy of metamizol, diclofenac, and propacetamol. J Pain Symptom Manage. 2002, 24:608-15. 10.1016\/s0885-3924(02)00520-1","journal-title":"J Pain Symptom Manage"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.5.445","article-title":"Cytokine-associated emotional and cognitive disturbances in humans","volume":"58","author":"Reichenberg A","year":"2001","unstructured":"Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollm\u00e4cher T. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry. 2001, 58:445-52. 10.1001\/archpsyc.58.5.445","journal-title":"Arch Gen Psychiatry"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1974.03230300021021","article-title":"Symptomatic therapy in viral illness. A controlled study of effects on work performance","volume":"228","author":"Beisel W","year":"1974","unstructured":"Beisel W, Morgan B Jr, Bartelloni P, Coates G, DeRubertis F, Alluisi E. Symptomatic therapy in viral illness. A controlled study of effects on work performance. JAMA. 1974, 228:581-4. 10.1001\/jama.1974.03230300021021","journal-title":"JAMA"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.31.2.410","article-title":"Effects of poststroke pyrexia on stroke outcome : a meta-analysis of studies in patients","volume":"31","author":"Hajat C","year":"2000","unstructured":"Hajat C, Hajat S, Sharma P. Effects of poststroke pyrexia on stroke outcome : a meta-analysis of studies in patients. Stroke. 2000, 31:410-4. 10.1161\/01.str.31.2.410","journal-title":"Stroke"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198111123052002","article-title":"Coronary vasoconstrictor effect of indomethacin in patients with coronary-artery disease","volume":"305","author":"Friedman PL","year":"1981","unstructured":"Friedman PL, Brown EJ Jr, Gunther S, Alexander RW, Barry WH, Mudge GH Jr, Grossman W. Coronary vasoconstrictor effect of indomethacin in patients with coronary-artery disease. N Engl J Med. 1981, 305:1171-5. 10.1056\/NEJM198111123052002","journal-title":"N Engl J Med"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(89)80461-5","article-title":"Acetaminophen: more harm than good for chickenpox?","volume":"114","author":"Doran TF","year":"1989","unstructured":"Doran TF, De Angelis C, Baumgardner RA, Mellits ED. Acetaminophen: more harm than good for chickenpox?. J Pediatr. 1989, 114:1045-8. 10.1016\/s0022-3476(89)80461-5","journal-title":"J Pediatr"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/162.6.1277","article-title":"Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers","volume":"162","author":"Graham NM","year":"1990","unstructured":"Graham NM, Burrell CJ, Douglas RM, Debelle P, Davies L. Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers. J Infect Dis. 1990, 162:1277-82. 10.1093\/infdis\/162.6.1277","journal-title":"J Infect Dis"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1592\/phco.20.19.1417.34865","article-title":"Effect of antipyretic therapy on the duration of illness in experimental influenza A, Shigella sonnei, and Rickettsia rickettsii infections","volume":"20","author":"Plaisance KI","year":"2000","unstructured":"Plaisance KI, Kudaravalli S, Wasserman SS, Levine MM, Mackowiak PA. Effect of antipyretic therapy on the duration of illness in experimental influenza A, Shigella sonnei, and Rickettsia rickettsii infections. Pharmacotherapy. 2000, 20:1417-22. 10.1592\/phco.20.19.1417.34865","journal-title":"Pharmacotherapy"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1186\/cc11211","article-title":"Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study","volume":"16","author":"Lee BH","year":"2012","unstructured":"Lee BH, Inui D, Suh GY, et al.. Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study. Crit Care. 2012, 16:R33. 10.1186\/cc11211","journal-title":"Crit Care"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3087505","article-title":"Effect of antipyretic therapy on mortality in critically ill patients with sepsis receiving mechanical ventilation treatment","volume":"2017","author":"Ye S","year":"2017","unstructured":"Ye S, Xu D, Zhang C, Li M, Zhang Y. Effect of antipyretic therapy on mortality in critically ill patients with sepsis receiving mechanical ventilation treatment. Can Respir J. 2017, 2017:10.1155\/2017\/3087505","journal-title":"Can Respir J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/220193-antipyretic-use-in-noncritically-ill-patients-with-fever-a-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:15:29Z","timestamp":1707509729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/220193-antipyretic-use-in-noncritically-ill-patients-with-fever-a-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":56,"URL":"https:\/\/doi.org\/10.7759\/cureus.51943","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,9]]}}}